AMI Integrity Test Systems  

Innovative solution for the pharmaceutical industry  

An innovative solution

Our patented method does not require any specific tracer gas. Instead, the gas mixture present in the container headspace of the primary packaging is used to perform high sensitivity tests over a large detection range. Therefore, our method is non-destructive, easy to use and to set up and has higher sensitivity than other conventional methods. AMI equipment has been qualified by leading pharmaceutical companies as in-process control (IPC) leak testing for blister packs. Our software is 21 CFR part 11 compliant.
 

Large detection range

Different detection methods can be combined in order to cover the complete detection range. Gross leak and fine leak tests are performed within a single test sequence, any additional gross leak test (e.g. blue dye ingress) can be omitted.
 

Deterministic test method

As no operator intervention is required, the measurement results are totally objective. High accuracy measurements can be achieved thanks to a calibration-validation sequence of the equipment based on certified calibrated leaks.
 

Therefore, high sensitivity tests combined with high throughput enables trend analysis to early indicate production issues and to avoid the loss of valuable pharmaceuticals.
 

How do you rate this page?
 

Recommend this page!
Social Networks:

This website uses cookies to ensure you get the best experience on our website. More info